MoneyWorks4Me

Hikal - Quaterly Results

08 Feb 2024 Evaluate
A decrease in the sales to Rs. 4475.70 millions was observed for the quarter ended December 2023. The sales stood at Rs. 5402.00 millions during the similar quarter previous year.The Net Profit of the company slipped to Rs. 162.70 millions from Rs. 264.10 millions, a decline of -38.39% on QoQ basis.Operating Profit reported a sharp decline to 649.50 millions from 770.90 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 4475.70 5402.00 -17.15 12705.00 14777.40 -14.02 20230.30 19427.20 4.13
Other Income 0.60 25.10 -97.61 19.90 70.30 -71.69 54.10 48.90 10.63
PBIDT 649.50 770.90 -15.75 1745.80 1740.10 0.33 2624.70 3454.50 -24.02
Interest 142.40 130.30 9.29 411.10 351.20 17.06 481.00 312.10 54.12
PBDT 507.10 640.60 -20.84 1334.70 1388.90 -3.90 2143.70 3142.40 -31.78
Depreciation 289.70 282.70 2.48 852.70 821.80 3.76 1090.10 956.70 13.94
PBT 217.40 357.90 -39.26 482.00 567.10 -15.01 1053.60 2185.70 -51.80
TAX 54.70 93.80 -41.68 125.50 144.00 -12.85 269.80 580.60 -53.53
Deferred Tax 3.10 -10.50 -129.52 1.70 -13.80 -112.32 -35.00 -15.90 120.13
PAT 162.70 264.10 -38.39 356.50 423.10 -15.74 783.80 1605.10 -51.17
Equity 246.60 246.60 0.00 246.60 246.60 0.00 246.60 246.60 0.00
PBIDTM(%) 14.51 14.27 1.69 13.74 11.78 16.69 12.97 17.78 -27.04
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..